Federal Circuit Affirms Indefiniteness Of "About" In Patent Claiming pH Range For Poultry Processing Method

Why It Matters

The ruling tightens the definiteness standard for patent claims, signaling higher drafting precision requirements for biotech and food‑processing inventions. It warns patentees that vague range language can jeopardize enforceability and commercial protection.

Key Takeaways

• Federal Circuit invalidated claims for lack of definite pH range.
• Approximation term “about” deemed indefinite without clear specification guidance.
• Conflicting experimental data prevented certainty on permissible pH deviation.
• Court emphasized precision when distinguishing from prior art.
• Patent drafting now requires explicit numeric boundaries for critical parameters.

Pulse Analysis

The Federal Circuit’s decision in Enviro Tech Chem. Servs., Inc. v. Safe Foods Corp. sharpens the legal bar for claim definiteness, a cornerstone of patent enforceability. By applying the de novo standard, the court underscored that any term of approximation—such as “about” or “approximately”—must be anchored in the intrinsic record with enough certainty to inform those skilled in the art. When the specification offers divergent experimental outcomes and the prosecution history lacks a consistent definition, the ambiguity becomes fatal, as illustrated by the pH‑range claim for peracetic‑acid poultry treatment.

Approximation language is common in biotech and food‑technology patents, where biological variability often prompts broader claim language. However, the Federal Circuit clarified that such breadth is permissible only when the patent’s disclosure delineates a clear tolerance, typically through explicit numerical limits or repeatable examples. In the present case, the patentee’s own data showed deviations both under and over 0.3 pH units, and the amendment history failed to lock down a consistent meaning. This creates a precedent that courts will scrutinize any “about” range that sits near prior‑art thresholds, demanding tighter definitions to avoid unfairly carving out narrow monopolies.

Practitioners must now revisit drafting strategies, especially for claims that hinge on critical process parameters like pH, temperature, or concentration. Including precise numerical bounds, detailed experimental protocols, and consistent terminology throughout the specification and prosecution history can mitigate indefiniteness risks. Moreover, counsel should anticipate potential challenges when a claim’s scope is designed to sidestep prior art, as the court expects heightened clarity in those contexts. Ultimately, the decision pushes the industry toward more rigorous claim construction, safeguarding patent validity while preserving the balance between innovation incentives and public domain access.